Cytosorbents Corporation
Organization details
- Legal name
- Cytosorbents Corporation
- Former names
- MedaSorb Technologies CORP Gilder Enterprises Inc
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 3841 — Surgical & Medical Instruments & Apparatus
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Princeton
- Headquarters state / province
- New Jersey
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- CTSO
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001175151
- EIN
- 98-0373793
Board of directors
-
Al Kraus · DirectorSince 2023
-
Alan D. Sobel · DirectorSince 2023
-
Edward Raymond Jones · DirectorSince 2023
-
Jiny Kim · DirectorSince 2023
-
Michael G. Bator · DirectorSince 2023
-
Phillip P. Chan · Director · Chief Executive OfficerSince 2023
Chief executives
Director election results
Annual meeting of August 13, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
87.2%
-
87.2%
-
87.8%
-
87.9%
-
91.4%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $269,332
- 10 purchases by 4 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 15, 2026 | Phillip P. Chan Director, Officer (Chief Executive Officer) | Open-market purchase | +3,774 | $6.00 | $22,644 |
| Sep 15, 2026 | Alan D. Sobel Director | Open-market purchase | +1,900 | $6.12 | $11,628 |
| Sep 15, 2026 | Alan D. Sobel Director | Open-market purchase | +500 | $6.05 | $3,025 |
| Sep 15, 2026 | Alan D. Sobel Director | Open-market purchase | +100 | $6.01 | $601 |
| Sep 14, 2026 | Capponi Vincent Officer (President and COO) | Open-market purchase | +1,800 | $6.07 | $10,926 |
| Sep 14, 2026 | Capponi Vincent Officer (President and COO) | Open-market purchase | +273 | $5.90 | $1,611 |
| Sep 4, 2026 | Phillip P. Chan Director, Officer (Chief Executive Officer) | Open-market purchase | +200,000 | $0.35 | $70,000 |
| Jun 15, 2026 | MARIANI PETER J Officer (Chief Financial Officer) | Open-market purchase | +100,000 | $0.44 | $44,000 |
| Jun 15, 2026 | Phillip P. Chan Director, Officer (Chief Executive Officer) | Open-market purchase | +10,333 | $0.43 | $4,443 |
| Jun 12, 2026 | Phillip P. Chan Director, Officer (Chief Executive Officer) | Open-market purchase | +251,136 | $0.40 | $100,454 |
| Nov 18, 2025 | Phillip P. Chan Director, Officer (Chief Executive Officer) | Grant or award | +100,000 | $0.64 | $64,000 |
| Aug 8, 2025 | Phillip P. Chan Director, Officer (Chief Executive Officer) | Grant or award | +105,600 | — | — |
| Aug 8, 2025 | MARIANI PETER J Officer (Chief Financial Officer) | Grant or award | +71,500 | — | — |
| Aug 8, 2025 | Capponi Vincent Officer (President and COO) | Grant or award | +89,100 | — | — |
| Aug 8, 2025 | Deliargyris Efthymios Officer (Chief Medical Officer) | Grant or award | +70,000 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Cytosorbents Corporation
Who is the CEO of Cytosorbents Corporation?
Phillip P. Chan is Cytosorbents Corporation's Chief Executive Officer.
How many directors are on Cytosorbents Corporation's board?
Cytosorbents Corporation's board has 6 directors: Al Kraus, Alan D. Sobel, Edward Raymond Jones, Jiny Kim, Michael G. Bator and Phillip P. Chan.
Are Cytosorbents Corporation insiders buying or selling shares?
Over the last 12 months, Cytosorbents Corporation insiders bought $269,332 of shares in 10 purchases and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="cytosorbents-corporation"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.